Initiatives for Lymphatic Filariasis

Activity List

• 
  Lymphatic Filariasis Elimination Activities in Myanmar

  September 1, 2020

• 
  DEC Project Managers' Efforts to Support Lymphatic Filariasis Elimination Activities

  February 13, 2020

• 
  Beating 10 Diseases, Improving 1 Billion Lives Participation in 5-Year Anniversary of London Declaration Event

  April 20, 2017

Current Distribution Status of DEC Tablets for Endemic Countries

• In November 2010, Eisai agreed to provide 2.2 billion DEC (diethylcarbamazine) tablets free of charge through WHO to lymphatic filariasis endemic countries worldwide by 2020
• In August 2013, Eisai's DEC tablets obtained prequalification from WHO, the first Neglected Tropical Disease treatment to receive prequalification in the world
• In October 2013, DEC tablet provision commenced from our Vizag plant
• In April 2017, Eisai announced that it would continue to provide DEC tablets to endemic countries that need them beyond 2020, until complete elimination is achieved

■Countries where DEC tablets are scheduled to be supplied by 2020

● Countries where distribution has commenced

• December 11, 2018

  Eisai Ranked 8th in the Access to Medicine Index 2018

• November 12, 2018

  Eisai Awarded Certificate of Appreciation by Department of Public Health, Ministry of Health and Sports of Myanmar for Donation of DEC Tablets

• January 20, 2017

  Eisai Participates in Access Accelerated, a Global Partnership to Advance Access to Non-Communicable Diseases Prevention, Treatment and Care in Low and Lower-Middle Income Countries